Format

Send to

Choose Destination
Drug Metab Lett. 2010 Apr;4(2):77-87.

Application of modern drug metabolism structure determination tools and assays to the in vitro metabolism of imiloxan.

Author information

1
Drug Metabolism and Pharmacokinetics, Roche Palo Alto LLC, Palo Alto, CA 94304, USA. bfitch@stanford.edu.

Abstract

Imiloxan is an alpha2 adrenoceptor antagonist and was developed for depression in the 1980's. In Phase 1 clinical trials imiloxan dosing led to hypersensitivity reactions; the molecule's development was discontinued. The present study revisits the in vitro metabolism of imiloxan using modern analytical methods. Human and rat liver microsomes convert imiloxan into a variety of metabolites many of which are unstable and or reactive. Imiloxan also yields high protein covalent binding in microsomal assays. Imiloxan is a useful test molecule for defining the relationship between liver covalent binding and idiosyncratic toxicity.

PMID:
20446913
DOI:
10.2174/187231210791292753
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Bentham Science Publishers Ltd.
Loading ...
Support Center